← Back
$LTRN All transactions

Lantern Pharma Inc.

D

$ Value

$0

Shares

26,100

Price

$0

Filed

Sep 23

Insider

Name

Margrave David R.

Title

Chief Financial Officer

CIK

0001813162

Roles

Officer

Transaction Details

Transaction Date

2021-10-29

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and one-third of the option vested 180 days from the grant date with the remaining two-thirds of the option vesting in equal monthly increments over the period commencing the 181st day after the grant date and ending 30 months thereafter (or 36 months after the grant date). | The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on October 29, 2021 and provides for vesting in equal monthly increments over a 36-month period commencing November 29, 2021.

Filing Info

Accession No.

0001493152-25-014612

Form Type

4

Issuer CIK

0001763950

Margrave David R.'s History

Date Ticker Type Value
2025-12-18 LTRN A $0
2021-10-29 LTRN D $0
2021-10-29 LTRN A $0
2020-06-15 LTRN D $0
2020-06-15 LTRN A $0

Other Insiders at LTRN (90d)

No other insider activity at this issuer in the last 90 days.